Zinc and Copper: Can You Take Them Together?

When zinc enters the intestinal lumen, it is absorbed by enterocytes (intestinal lining cells) and triggers the transcription of metallothionein genes via the metal-responsive transcription factor MTF-1. Metallothionein is a cysteine-rich metal-binding protein that serves as an intracellular metal buffer. The critical problem is one of binding affinity: metallothionein binds copper (Cu+) with approximately 100-fold greater affinity than zinc (Zn2+), because copper forms more thermodynamically stable thiolate bonds with metallothionein's cysteine residues. Once copper is bound to metallothionein inside the enterocyte, it cannot be released to the basolateral copper transporter ATP7A for export into the bloodstream. Enterocytes have a 3-5 day lifespan before being shed into the intestinal lumen and excreted — taking the trapped copper with them.

This mechanism is dose-dependent and cumulative. At zinc intakes below 25mg per day, metallothionein induction is minimal and copper absorption proceeds normally. Between 25-40mg, metallothionein production increases but most individuals maintain adequate copper balance through dietary compensation. Above 40mg daily — which exceeds the Tolerable Upper Intake Level (UL) set by the Institute of Medicine — metallothionein induction becomes sufficient to sequester a clinically significant fraction of dietary copper. Within 2-3 months of chronic high-dose zinc supplementation, copper stores deplete to the point where ceruloplasmin (the primary copper transport protein in blood) drops below functional thresholds. The resulting copper deficiency presents as sideroblastic anemia that mimics iron deficiency but does not respond to iron, neutropenia (leaving the individual immunocompromised), and in severe or prolonged cases, copper-deficiency myelopathy — a progressive spinal cord degeneration that closely resembles B12-deficiency myelopathy on MRI, per PMID 2296467.